- Home
- About
- Find staff
- David Larsson
David Larsson
Affiliated to Research
Department of Clinical Neuroscience-
Short-term sick leave due to epilepsy in the Swedish Prospective Regional Epilepsy Database and Biobank for Individualized Clinical Treatment
(PREDICT)
Kerstin Andrén, David Larsson, Fredrik Asztely, Johan Zelano
EPILEPSIA OPEN - 2025 -
Higher plasma total tau concentrations among patients reporting CNS-related side effects from antiseizure
medication
Klara Andersson, Sarah Akel, Fredrik Asztely, David Larsson, Henrik Zetterberg, Johan Zelano
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY - 2025 -
Antiseizure Medications in Poststroke
Seizures
Shubham Misra, Selena Wang, Terence J. Quinn, Jesse Dawson, Johan Zelano, Tomotaka Tanaka, James C. Grotta, Erum Khan, Nitya Beriwal, Melissa C. Funaro, Sravan Perla, Priya Dev, David Larsson, Taimoor Hussain, David S. Liebeskind, Clarissa Lin Yasuda, Hamada Hamid Altalib, Hitten P. Zaveri, Amr Elshahat, Gazala Hitawala, Ethan Y. Wang, Rachel Kitagawa, Abhishek Pathak, Fabien Scalzo, Masafumi Ihara, Katharina Stibrant Sunnerhagen, Matthew R. Walters, Yize Zhao, Nathalie Jette, Scott E. Kasner, Patrick Kwan, Nishant K. Mishra
NEUROLOGY - 2025 -
Cardiovascular risk factor assessment in late-onset seizures: A study protocol to assess the value of structured
intervention
David Larsson, Signild Asberg, Johan Sundstrom, Petrea Frid, Johan Zelano
EPILEPSIA OPEN - 2024 -
Second antiseizure medication monotherapy in patients with adult-onset epilepsy: A register-based
analysis
Konstantinos Polychronidis, Samuel Håkansson, Saman Hosseini Ashtiani, André Idegård, David Larsson, Johan Zelano
EPILEPSY & BEHAVIOR - 2024 -
Antiseizure medication selection and retention for adult onset focal epilepsy in a Swedish health service region: A population-based cohort
study
David Larsson, D. Mroue, K. Andren, Johan Zelano
Epilepsia - 2023 -
Prevalence and nature of patient-reported antiseizure medication side effects in a Swedish regional multi-center
study.
Johan Zelano, Olha Nika, Fredrik Asztely, David Larsson, Klara Andersson, Kerstin Andrén
Seizure - 2023 -
Adherence to anti-seizure medications in the Swedish Prospective Regional Epilepsy Database and Biobank for Individualized Clinical Treatment
(PREDICT)
Kerstin Andrén, David Larsson, Fredrik Asztely, Johan Zelano
Epilepsy and Behavior Reports - 2023 -
Association Between Antiseizure Drug Monotherapy and Mortality for Patients With Poststroke
Epilepsy
David Larsson, A. Baftiu, C. J. Landmark, M. von Euler, E. Kumlien, S. Asberg, J. Zelano
JAMA Neurology - 2022 -
Acquired Epilepsy with a Focus on Stroke: Treatment and
Prognosis
David Larsson
2022 -
Quantitative proteomic analysis to identify differentially expressed proteins in patients with
epilepsy
Rakesh Kumar Banote, David Larsson, Evelin Berger, E. Kumlien, Johan Zelano
Epilepsy Research - 2021 -
Brain injury markers in new-onset seizures in adults: A pilot
study
Hanna Eriksson, Rakesh Kumar Banote, David Larsson, Kaj Blennow, Henrik Zetterberg, Johan Zelano
Seizure-European Journal of Epilepsy - 2021 -
Potential for improved retention rate by personalized antiseizure medication selection: A register-based
analysis
Samuel Håkansson, Markus Karlander, David Larsson, Zamzam Mahamud, S. Garcia-Ptacek, A. Zelezniak, Johan Zelano
Epilepsia - 2021 -
Risk of stroke after new-onset
seizures
David Larsson, B. Farahmand, S. Asberg, Johan Zelano
Seizure-European Journal of Epilepsy - 2020 -
Retention rate of first antiepileptic drug in poststroke epilepsy: A nationwide
study
David Larsson, S. Åsberg, E. Kumlien, Johan Zelano
Seizure - 2019 -
Pre-stroke seizures: A nationwide register-based
investigation
Johan Zelano, David Larsson, E. Kumlien, S. Asberg
Seizure-European Journal of Epilepsy - 2017